SCIENTIFIC PANEL

Tallal
Younis
NOYCIA Chair
MBBCh, FRCP (UK)
Jamil
Asselah
MD
Medical
Oncologist
Scott
North
MPHE, MD, FRCPC
Ravi
Ramjeesingh
MD, Ph.D, FRCPC
Christine
Simmons
MD, MSc, FRCPC
Paul
Wheatley-Price
MD, FRCPC, FACP

Tallal Younis
NOYCIA Chair
MBBCh, FRCP (UK)

Dr. Younis is a professor of medicine at Dalhousie University, and a consultant medical oncologist at the Queen Elizabeth II Health Sciences Centre (QE II HSC) in Canada. He received his medical degree from Cairo University in 1992 and an MRCP degree from the United Kingdom in 1998. He completed an internal medicine residency in 2001 at the Columbia University and a medical oncology fellowship in 2003 at the Roswell Park Cancer Institute in the USA.

Dr. Younis clinical practice is devoted to breast cancer, and he is board certified (ABIM) in internal medicine and medical oncology. He is the research director for medical oncology at the QEII HSC, and an editor for “Current Oncology” journal. His research interests involve health services research and health technology assessments in breast cancer.

JAMIL ASSELAH
MD, Medical Oncologist

Trained in Algiers and Paris as a medical oncologist, Dr. Asselah completed a 2-year fellowship on phase 1 clinical trials at the Investigation Unit of the Curie Institute Cancer Centre in Paris, France.

In 2008, he joined the Université de Sherbrooke as an Assistant Professor, developing new research protocols in breast cancer and standardizing treatment practices at the Centre Hospitalier Universitaire de Sherbrooke, where he also launched the oncology residency program.
He joined McGill in 2011 as an Assistant Professor in the Department of Oncology and is now Associate Professor and director of Oncology Undergraduate Medical Education. He is on staff as a medical oncologist at the McGill University Health Centre, where he spearheaded a working group standardizing treatment guidelines for breast cancer. He was the first Site Lead for the Rossy Cancer Network.

Dr. Asselah has been the principal investigator in numerous clinical research protocols, and has been part of several research groups at the Provincial and National level. His research interests include Breast Cancers, Gastrointestinal Cancers, and Cancers of the Head and Neck.

Scott North
MHPE, MD, FRCPC

Scott North received his MD degree from the University of Ottawa and then completed Internal Medicine and Medical Oncology training at the University of Alberta. He has a keen interest in medical education, also obtaining a Masters in Health Professions Education from the University of Illinois at Chicago. He is a Professor in the Department of Oncology at the University of Alberta and currently the Section Chief of Medical Oncology at the Cross Cancer Institute in Edmonton and the Division Head of Medical Oncology within the Department of Oncology at the University of Alberta. His clinical interests are in the area of genitourinary oncology and he is an active clinical trialist. He is currently a member of the national executive of the Candadian Uro-Oncology Group (CUOG) and the GU site of the CCTG.

Ravi Ramjeesingh
MD, Ph.D, FRCPC

Dr. Ravi Ramjeesingh is a Medical Oncologist and Assistant Professor in both the Department of Medicine and Department of Community Health and Epidemiology at Dalhousie University.

Dr. Ravi Ramjeesingh obtained his MD in 2008 and PhD in 2004 from the University of Toronto where his research focused on cell signaling in cancer models. He completed both his residency training in internal medicine and medical oncology at Queen’s University. He then undertook a two-year clinical trial methodology fellowship with the CCTG (formerly NCIC Clinical Trials Group) at Queen’s University where he was awarded a CAMO/CIHR Fellowship Award in 2013 and a AACR Scholar-in- Training Award in 2014. His current areas of specialization include gastrointestinal cancers (specializing in hepatocellular carcinoma, pancreatic and cholangiocarcinomas), breast cancer, and melanoma. His current research includes health service outcomes in hepato-pancreatic- biliary and colorectal cancers. He is the current lead and co-investigator for several pharmaceutical sponsored clinical trials as well as cooperative group trials. He additionally has a passion for education of learners. He is currently involved in the Medical Oncology Residency Program Committee as well as a faculty member of OncologyEducation.com. His interests in education has led to him being awarded the Dalhousie University Medical Oncology Teacher of the Year Award in 2016.

Christine Simmons
MD, MSc, FRCPC

Dr. Christine Simmons is a Medical Oncologist at the BCCA Vancouver and Clinical Associate Professor in the Department of Medicine at the University of British Columbia. She completed her residency training in Toronto, and completed a fellowship at Princess Margaret Hospital in Toronto. She also completed a Master’s in Clinical Epidemiology at University of Toronto. She is currently the Chair of Sarcoma Systemic Program for BCCA. She is the former chair of the Locally Advanced Breast Cancer National Consensus group and still plays a key role in that organisation. Her academic interests span both teaching and research, and she has held several leadership roles in the Undergraduate Medical Program at UBC in the areas of clinical skills and oncology education. Her research interests are in the areas of health services research in breast cancer and sarcoma. She recently founded the Sarcoma Outcomes Unit at the BC Cancer Agency, and is Founder and Chair of the not-for-profit organisation, Women in Cancer.

Paul Wheatley-Price
MD, FRCPC, FACP

Dr Wheatley-Price is a medical oncologist at The Ottawa Hospital, with an academic appointment at the University of Ottawa. His research interests are in thoracic oncology, with an emphasis on systemic therapy in challenging clinical scenarios, and in the rare cancer types mesothelioma and thymoma.

He is active in lung cancer advocacy, in June 2016 becoming President of Lung Cancer Canada, a national charity supporting patients and caregivers living with lung cancer, and promoting advocacy and research.

He is also a young leader in medicine, having recently completed the OMA Physician Leadership Development Program, and in the summer of 2016 became Deputy Division Head of Medical Oncology.